Clinical Trial Update: DUS on the Prescribing Indications for CPA/EE in 5 European Countries

View source ↗

Summary

Clinical trial update on prescribing indications for CPA/EE across five European countries; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Anemia
• Hirsutism
• Polycystic Ovary Syndrome
• Seborrhea

Drugs mentioned

• CPA/EE

Snippet

Sponsor: Center for Epidemiology and Health Research, Germany | Conditions: Hirsutism, Androgenetic Alopecia | Status: COMPLETED | Results posted: 2021-08-27